Acquisition - April 16, 2016
Recipharm creates global CDMO through new acquisitions
Swedish CDMO Recipharm continues to expand. Most recently the company acquired Kemwell’s pharmaceutical CDMO businesses. In February Recipharm acquired privately owned Italian CDMO Mitim, adding important technology in the filling of injectable beta lactams with sales to the US and European markets. The transaction is valued at an enterprise value of EUR 68 million. The […]
In a new job - September 8, 2014
Kemwell gets new CEO
The contract pharmaceutical development and manufacturing company has appointed Mikael Ericson as new CEO. According to a statement from Kemwell Mikael Ericson is highly experienced in production, logistics and lean management and has held various international management positions in large corporations in both pharmaceutical and automotive industries, such as AstraZeneca, Scania and Plastal Industri. “With his […]